Sylvette Nazario, MD
Allergy & Immunology · Hato Rey, PRNPI 1700810165
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,413 of the $1,866 with a category attached, or 75.7%. Sanofi accounts for 77.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $1,413 and has fallen 93.0% since, to $99 in 2025. That places this record below the midpoint for allergy & immunology clinicians in PR, where the typical reported total is $2,799.
Across 12 payments — averaging $155.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- Sanofi-aventis U.S. LLC$135
- Amgen$121
- Genentech USA, Inc.$45
- Mallinckrodt Hospital Products Inc.$34
- AstraZeneca$29
- plus $48 from 2 others
Across 21 payments — averaging $1913.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$35K
- Regeneron$3K
- Sanofi US Services Inc.$1K
What the payments were for
- Consulting fees$1,41376%
- Food & beverage$34719%
- Education$1066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $1,453 |
| Sanofi-aventis U.S. LLC | 2 | $135 |
| Amgen(2 entities) | 2 | $121 |
| Genentech USA, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| AstraZeneca | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Genentech, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$1,413
How this compares
$1,866 in reported general payments places this provider in the 45th percentile of 25 allergy & immunology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $45,151 |
| Azelastine Hcl | 17 | $293 |
| Levothyroxine Sodium | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Hato Rey
- Sybelle Serrano SantiagoHato Rey$4K
- Angel RiveraHato Rey$2K
- Cristina RamosSan Juan$441K
- Jose MorenoSan Juan$93K
- Wilfredo Cosme BlancoAguadilla$53K
- Anardi Agosto-MujicaCayey$42K
- Erving Arroyo FloresBayamon$6K
- Giannina Coppola-FasickCarolina$5K
- Veronica Diaz VidalCaguas$5K
- Jose Zaragoza BuxoArecibo$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.